Dr Adele Hosseini B.Pharm, M.Pharm, PhD

Chief Scientific Officer, Bod Australia Dr. Adele Hosseini, Chief Scientific Officer for Bod Australia, is pioneering into medicinal cannabis for commercialisation.

About this speaker

As a trained pharmacist with over 25 years leadership in pharmaceuticals Dr. Hosseini brings a breadth and depth of experience in the research and regulatory requirements for registration of cannabis and other medicines.

Dr. Hosseini has thorough understanding of medicinal cannabis and actively works to build knowledge and shape the future of the global pharmaceutical medicinal cannabis industry.

Contact This Speaker


Scientifically Validated Applications of a CBD-Dominant Medicine for Clinical Practice – Using Real-World Evidence to Support Patient Outcome

25 November 2021, 11:40 PM
Adele Hosseini